The TRIM28 gene helps control when many other genes are turned on or off, especially during early development, and it also supports DNA repair. If this gene does not work properly, cells may lose some control over normal growth and development. Pathogenic variants in the TRIM28 gene have been linked to developmental delay, learning difficulties, and differences in growth or body features in some people. In some families, changes in this gene are also linked to a higher chance of certain childhood kidney tumors.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or regulate activities in the body. Some genes provide the directions for building proteins, which do much of the work inside cells. Others mainly guide when certain processes take place, where they occur, and how active they are. Taken together, genes affect how the body develops and works, and they may influence how you respond to food, stress, or medicines. For a deeper look at this topic, you can read more in LearnHub.
Overview
TRIM28Gene function
What if the gene works
The TRIM28 gene helps control which genes are switched on or off in your cells. Its protein supports normal growth, early development, and stable DNA packaging. It also helps cells respond to DNA damage and keep repetitive DNA quiet.
Risk
What if the gene does not work
More disruptive variants in the TRIM28 gene are best known for increasing the chance of childhood Wilms tumor, and some people may also have developmental differences. Milder variants may have less effect or different features.
Treatment
What does that mean for your treatment
For pathogenic variants in the TRIM28 gene, no treatment or management approach tied specifically to this gene is currently established in clinical guidelines. The TRIM28 gene is being studied as a cancer biomarker and possible drug target in several tumors, but this has not changed routine drug choices.
Conditions associated with TRIM28
Gene function
What if the gene works
Inside your cells, the TRIM28 gene helps manage which stretches of DNA stay active and which stay quiet. Its protein mainly acts as a coordinator, bringing other proteins to selected places along DNA. This supports orderly gene activity and stable DNA packaging.
The TRIM28 gene helps cells lower the activity of selected genes at the right time. Its protein does this by teaming up with proteins that recognize DNA and other gene control helpers.
It helps organize some DNA into a tighter, quieter form called heterochromatin (densely packed DNA). This packaging makes it easier for cells to keep certain stretches of DNA switched down.
The TRIM28 gene helps keep repetitive DNA and DNA sequences that can copy or move around quiet. This supports genome stability and is a key part of how the TRIM28 gene helps control gene activity.
Its protein acts as a landing platform for several cell helpers that adjust gene activity and DNA packaging. By bringing these partners together, cells can manage routine gene control in a more organized way.
What is a variant?
A genetic variant is a slight change within the DNA sequence of a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, and the way the body responds to environmental influences. Many have no visible effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene works more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the TRIM28 gene can change the protein's shape, make it less stable, or disrupt the regions it uses to bind other cell proteins, which helps explain how TRIM28 gene variants affect protein function. Milder variants may leave some activity in place, while more disruptive variants can reduce activity or produce a shortened protein that is broken down early. This loss of function can vary from partial to marked, which may influence how much gene regulation is disturbed.
How variants are linked to conditions
Pathogenic variants in the TRIM28 gene are linked to Wilms tumor predisposition, an inherited tendency to develop Wilms tumor, a childhood kidney cancer. This is the main well-established TRIM28 gene condition association in human genetics. Carrying a TRIM28 variant does not mean a child will definitely develop cancer, but it does raise the chance compared with the general population.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widely found in the general population. Most do not directly affect health and instead reflect normal human diversity. For many genes, having a variant associated with a condition indicates a possible link rather than a definitive diagnosis, especially when multiple genes and environmental influences are involved. In some situations, though, a single well characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There isn't yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the TRIM28 gene. In families with a disease-causing TRIM28 change, risk is mainly tied to the genetic change itself, so care often focuses on monitoring and early detection rather than lifestyle changes alone.
Inheritance of TRIM28 variants
TRIM28-related conditions that have a clearly established inheritance pattern are usually inherited in an autosomal dominant way. That means a person with a disease-causing variant in the TRIM28 gene can pass it to each child with a 50% chance. In some families, the variant is inherited from an affected parent, while in others it can appear for the first time as a new variant in the child. When people look up how TRIM28 gene variants are inherited, the main pattern described is autosomal dominant, although the health effects can vary from one person to another.
What does my TRIM28 result mean for my family?
Some inherited changes in the TRIM28 gene are linked to a higher chance of Wilms tumor, a kidney cancer that usually affects young children. In families with this kind of result, close relatives such as parents, brothers, sisters, and children may also carry the same change, so the result can matter beyond one person. Some family members may have the gene change even if they have never had cancer.
Genetic information
Genetic testing
How you find out about variants
To look for changes in the TRIM28 gene, genetic testing for TRIM28 variants usually uses a blood or saliva sample. A lab reads the DNA sequence and checks for variants, then reports whether a change was found and how it is currently classified.
When should I consider getting a genetic test?
Testing for the TRIM28 gene may be considered in a child with Wilms tumor, a kidney cancer that usually affects young children, especially when it happens at a very young age or runs in the family. It can help show whether there is an inherited risk for the child and close relatives.
A genetic result is only one part of your health story
A genetic test result can be informative, but the amount it can tell you varies with the condition and the kind of variant that is present. Over time, many factors, including lifestyle, environment, age, and medical history, also influence how the body functions. For some conditions, particularly those shaped by many genes, genetic information provides context rather than certainty and makes the most sense when considered with other parts of care. In other situations, a genetic finding may give a clear answer. In areas like medication response, genetic results can also help put personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Small differences in DNA can change how quickly a drug is processed, how strongly it acts, or how sensitive someone is to side effects. This helps explain why the same medication works well for one person, works less well for another, or causes more unwanted effects in someone else. These differences are common and are one part of why treatment response varies from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medicines. By studying links between genes and medications, it helps explain why the same treatment can work differently in different people. For many drugs, genes influence how strongly a medicine works or how the body handles it. This information can support more informed and more individualized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the TRIM28 gene
When should I seek medical advice?
There isn't yet a broadly confirmed role for this gene in guiding routine medication choices, so questions about side effects, treatment response, or starting a new medicine are best discussed with your doctor. TRIM28 has been studied in cancer research for possible links to how some tumors respond to treatment, but this is not used in standard prescribing.
History
TRIM28 entered the scientific literature in the 1990s, when researchers studying how genes are switched on and off identified a protein first called TIF1β. Soon after, the same protein was also described as KAP1, and later it became widely known by its official name, the TRIM28 gene. From these first observations, research expanded steadily, linking TRIM28 to several major lines of genetics research, including gene control, early development, and cancer biology. As naming systems became more standardized, scientists brought these earlier labels together under TRIM28, which helped unify findings from different fields. Over time, scientists’ understanding of the gene’s role has changed, and TRIM28 remains an important reference point in modern molecular genetics.